SANASana Biotechnology, Inc.
$2.80-32% 1Y
$2.80
$2.6852 weeks$5.92
What is the market doing?
Watch
1 to watch, 2 without dataIn a downtrend (−21% vs 200-day). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendDowntrendderived · Oct 8, 2026
In a downtrend, below its 50- and 200-day averages. Price is −21% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How SANA is trading
Sana Biotechnology, Inc. is −32% over the past year while the S&P 500 is +18%: 50 points behind the market.
−32%
1-year return · S&P 500 +18%
- vs 200-day average
- −21%
vs 200-day average · a clear downtrend
- RSI (14)
- 34
RSI (14) · neutral
- Below its 52-week high
- 53%
Below its 52-week high
Details›
- Last close2026-10-08
- $2.80
- 1 monthS&P 500 +1.6%
- −12%
- 1 yearS&P 500 +18%
- −32%
- 5 yearsS&P 500 +86%
- −88%
- vs 50-day average$3.40
- −18%
- 52-week high
- $5.92
- 52-week low
- $2.68
- Annualised volatility
- 149%
| Year | Return |
|---|---|
| 2026 (year to date) | −31% |
| 2025 | +150% |
| 2024 | −60% |
| 2023 | +3.3% |
| 2022 | −74% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 4 of 5 | +23% |
| Feb | 5 | 1 of 5 | +2.6% |
| Mar | 6 | 2 of 6 | −7.0% |
| Apr | 6 | 3 of 6 | +5.8% |
| May | 6 | 3 of 6 | −3.8% |
| Jun | 6 | 3 of 6 | +3.7% |
| Jul | 6 | 3 of 6 | +5.9% |
| Aug | 6 | 3 of 6 | +6.5% |
| Sep | 6 | 1 of 6 | −14% |
| Oct | 6 | 1 of 6 | −2.5% |
| Nov | 5 | 1 of 5 | −3.8% |
| Dec | 5 | 1 of 5 | −17% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.